Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02068352 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis
A Phase 2 study, sponsored by Otsuka Pharmaceutical Development & Commercialization.
- Completed
- Registry status
- Phase 2
- Development phase
- 121
- Enrollment target
NCT02068352 is a Phase 2 study that has completed, run by Otsuka Pharmaceutical Development & Commercialization. The registered enrollment target is 121 participants.
The verdict
NCT02068352, a Phase 2 study, has completed, sponsored by Otsuka Pharmaceutical Development & Commercialization.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 121 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the effectiveness and safety of 2 concentrations of OPA-15406 compared to vehicle in participants with atopic dermatitis (AD).
Interventions
- DRUG OPA-15406
- DRUG Vehicle ointment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2014-06-20 |
| Est. Completion | 2015-02-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02068352
The ClinicalTrials.gov registry entry for NCT02068352 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Otsuka Pharmaceutical Development & Commercialization, which has 221 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which OPA-15406 is the first listed.
NCT02068352 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02068352 about?
NCT02068352 is a clinical study titled "A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis". The purpose of this study is to investigate the effectiveness and safety of 2 concentrations of OPA-15406 compared to vehicle in participants with atopic dermatitis (AD).
What is the current status of trial NCT02068352?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 121 participants. The study started on 2014-06-20. Estimated completion is 2015-02-03.
What interventions are being tested in trial NCT02068352?
The interventions under investigation include: OPA-15406 (DRUG), Vehicle ointment (DRUG).
Who is sponsoring clinical trial NCT02068352?
This trial is sponsored by Otsuka Pharmaceutical Development & Commercialization, which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.